Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.
Case Library Membership
Search free — but unlock advanced filters to find every case involving a specific company or clause.
Already a member? Sign in →
Case Library Membership
inc. VAT
inc. VAT · cancel any time
Secure payment via Stripe
Need access for your team?
Company licences available for compliance teams, medical affairs, and training programmes.
Get a team quote →1,930 cases found
A dermatologist alleged a Ranbaxy letter implied Co-Cyprindiol contained isotretinoin and erythromycin. The Panel found no breach of Clause 7.2, but said…
Two BMJ advertisements for Gaviscon Advance used in-vitro data but implied in-vivo/clinical oesophageal protection and wider clinical benefit. The Panel ruled both…
A rheumatologist complained that an RCP webcast sponsored by Roche effectively promoted rituximab. The Panel found sponsorship was transparent and arm’s length,…
Complaint about Lantus promotional leavepieces and a mailer. Issues included “24-hour efficacy” wording and a hypoglycaemia comparison based on pooled observational data.…
GSK challenged Pfizer’s Champix detail aid on efficacy comparisons vs NRT, NNT and cost-effectiveness claims, and safety/prescribing information. The Panel ruled no…
A nurse alleged she was told Ferinject was safe and could be given as 1,000mg in 15 minutes. The Panel found insufficient…
A nurse alleged a sponsored symposium discussion implied an EpiPen could replace cardio-pulmonary resuscitation for IV iron reactions. The Panel could not…
A rheumatologist complained that an RCP webcast sponsored by Roche effectively promoted rituximab. The Panel found Roche’s sponsorship was transparent and arm’s…
Complaint about Lantus promotional leavepieces and a mailer. Issues included “24-hour efficacy” wording and comparative hypoglycaemia claims based on pooled observational data.…
GSK challenged Pfizer’s Champix detail aid claims on quit rates, NNT, cost-effectiveness and safety information. The Panel found the data were presented…
A nurse alleged misleading claims about Ferinject dosing and safety at a Syner-Med exhibition stand and in a detail aid. The Panel…
A nurse complained that discussion at a Syner-Med sponsored symposium implied an EpiPen could replace cardio-pulmonary resuscitation for IV iron reactions. The…
A primary care trust chief pharmacist complained about a Plavix leavepiece and representative conduct. The Panel ruled it was misleading to imply…
A Gardasil press release and follow-up PR emails after the UK chose Cervarix for the national HPV programme were ruled misleading, exaggerated…
AstraZeneca challenged Trinity-Chiesi’s Fostair cost comparison chart as incomplete and misleading. The Panel found the chart acceptable in context and ruled no…
Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.
